NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹257 Cr | ₹217 Cr | ₹198 Cr | ₹149 Cr | ₹94 Cr |
What is the latest Profit & Loss Account Balance ratio of NGL FINECHEM ?
Year | Profit & Loss Account Balance |
---|---|
Mar2024 | ₹257 Cr |
Mar2023 | ₹217 Cr |
Mar2022 | ₹198 Cr |
Mar2021 | ₹149 Cr |
Mar2020 | ₹94 Cr |
How is Profit & Loss Account Balance of NGL FINECHEM Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2024 | ₹257 Cr | 18.45 | |
Mar2023 | ₹217 Cr | 9.77 | |
Mar2022 | ₹198 Cr | 32.69 | |
Mar2021 | ₹149 Cr | 59.25 | |
Mar2020 | ₹94 Cr | - |
Compare Profit & Loss Account Balance of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹686.6 Cr | -0.6% | 6.7% | -47.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -0.6% |
6.7% |
-47.1% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses